Ultrashort-Acting β-Blockers: Are We on the Right Path?

Chest. 2021 Jun;159(6):2139-2140. doi: 10.1016/j.chest.2021.02.004.

Authors

Andrea Morelli¹, Filippo Sanfilippo²

Affiliations

¹ Department of Internal Clinical, Anesthesiological and Cardiovascular Sciences, University of Rome, Rome, Italy. Electronic address: andrea.morelli@uniroma1.it.
² Department of Anaesthesia and Intensive Care, "Policlinico-Vittorio Emanuele" University Hospital, Catania, Italy.

PMID: 34099120
DOI: 10.1016/j.chest.2021.02.004

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Adrenergic beta-Antagonists / pharmacology*
Autonomic Nervous System* / drug effects
Autonomic Nervous System* / physiopathology
Catecholamines / metabolism
Catecholamines / pharmacokinetics
Hemodynamics / drug effects
Humans
Shock, Septic* / metabolism
Shock, Septic* / physiopathology
Shock, Septic* / therapy
Tachycardia / metabolism
Tachycardia / physiopathology
Ventricular Function / drug effects

Substances

Adrenergic beta-Antagonists
Catecholamines